Evidence map›Paper›PMID 24854385›Full record

ReviewMetabolism: clinical and experimental2014

Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Wen-Jun Shen, Jie Hu, Zhigang Hu, Fredric B Kraemer, Salman Azhar

Open access · greenAbstract readReview
In one paragraph

Review in Metabolism: clinical and experimental, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Marine drugs · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Scavenger receptor class B, type 1 facilitates cellular fatty acid uptake.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2020
    Article
  20. The Roles of Lipoprotein in Psoriasis.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Wen-Jun ShenGeriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California 94304; Division of Endocrinology, Stanford University, Stanford, California 94305.
Jie HuGeriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California 94304.
Zhigang HuGeriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California 94304; Division of Endocrinology, Stanford University, Stanford, California 94305.
Fredric B KraemerGeriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California 94304; Division of Endocrinology, Stanford University, Stanford, California 94305.
Salman AzharGeriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California 94304; Division of Gastroenterology and Hepatology, Stanford University, Stanford, California 94305. Electronic address: salman.azhar@va.gov.
Stanford University · USGeriatric Research Education and Clinical Center · USVA Palo Alto Health Care System · US

Funding

HOW DO CELLS PROCESS HIGH DENSITY LIPOPROTEINS?R01HL033881 · NHLBI · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI AZHAR, SALMAN · 1985 to 2014
$3.8M
LipolysisI01BX000398 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI KRAEMER, FREDRIC B. · 2009 to 2020
–
BLRD VA I01 BX000398NHLBI NIH HHS R01 HL033881NHLBI NIH HHS R01HL33881
6 · The paper itself

Abstract

Scavenger receptor class B type I (SR-BI), is a physiologically relevant HDL receptor that mediates selective uptake of lipoprotein (HDL)-derived cholesteryl ester (CE) in vitro and in vivo. Mammalian SR-BI is a 509-amino acid, ~82 kDa glycoprotein that contains N- and C-terminal cytoplasmic domains, two-transmembrane domains, as well as a large extracellular domain containing 5-6 cysteine residues and multiple sites for N-linked glycosylation. The size and structural characteristics of SR-BI, however, vary considerably among lower vertebrates and insects. Recently, significant progress has been made in understanding the molecular mechanisms involved in the posttranscriptional/posttranslational regulation of SR-BI in a tissue specific manner. The purpose of this review is to summarize the current body of knowledge about the events and molecules connected with the posttranscriptional/posttranslational regulation of SR-BI and to update the molecular and functional characteristics of the insect SR-BI orthologs.

Indexed as

AnimalsBiological TransportGene Expression RegulationGlycosylationHumansInsect ProteinsLipoproteins, HDLLiverOrgan SpecificityProtein ConformationProtein Processing, Post-TranslationalReceptors, LipoproteinScavenger Receptors, Class BSpecies Specificityhigh density lipoprotein receptorsInsect ProteinsLipoproteins, HDLReceptors, LipoproteinSCARB1 protein, humanScavenger Receptors, Class BHDL receptorSelective uptakeSteroid hormones

Identifiers

PMID24854385
PMCPMC8078058
OpenAlexW2107827164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.